Aerpio Pharmaceuticals, Inc.
Multispecific antibodies that target HPTP-.beta. (VE-PTP) and VEGF

Abstract:

The disclosure provides compositions comprising multi-specific compounds, including a compound that targets a phosphatase and a receptor tyrosine kinase agonist. Also provided are methods for the treatment of conditions associated with angiogenesis, comprising administering a multi-specific compound that targets a phosphatase and a receptor tyrosine kinase agonist.